Journal for ImmunoTherapy of Cancer (Nov 2020)

631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform

Dahea Lee,
Donggeon Kim,
Soomin Ryu,
Byoung Chul Lee

Affiliations

Dahea Lee: Kanaph Therapeutics, Seoul, Korea, Republic of
Donggeon Kim: Kanaph Therapeutics, Seoul, Korea, Republic of
Soomin Ryu: Kanaph Therapeutics, Seoul, Korea, Republic of
Byoung Chul Lee: Kanaph Therapeutics, Seoul, Korea, Republic of

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0631
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal